271
TITLE: Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients
AUTHORS: Van Vaerenbergh, K; Harrer, T; Schmit, JC; Carbonez, A; Fontaine, E; Kurowski, M; Grunke, M; Low, P; Rascu, A; Schmidt, B; Schmitt, M; Thoelen, I; Walter, H; Van Laethem, K; Van Ranst, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLISHED: 2002, SOURCE: AIDS RESEARCH AND HUMAN RETROVIRUSES, VOLUME: 18, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
272
TITLE: Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny
AUTHORS: Courgnaud, V; Salemi, M; Pourrut, X; Mpoudi Ngole, E; Abela, B; Auzel, P; Bibollet Ruche, F; Hahn, B; Vandamme, AM; Delaporte, E; Peeters, M;
PUBLISHED: 2002, SOURCE: JOURNAL OF VIROLOGY, VOLUME: 76, ISSUE: 16
INDEXED IN: Scopus WOS CrossRef
273
TITLE: Complete genome sequence of Montana Myotis leukoencephalitis virus, phylogenetic analysis and comparative study of the 3 ' untranslated region of flaviviruses with no known vector
AUTHORS: Charlier, N; Leyssen, P; Pleij, CWA; Lemey, P; Billoir, F; Van Laethem, K; Vandamme, AM; De Clercq, E; de Lamballerie, X; Neyts, J;
PUBLISHED: 2002, SOURCE: JOURNAL OF GENERAL VIROLOGY, VOLUME: 83, ISSUE: 8
INDEXED IN: Scopus WOS
274
TITLE: Complete genome sequence, taxonomic assignment, and comparative analysis of the untranslated regions of the Modoc virus, a flavivirus with no known vector  Full Text
AUTHORS: Leyssen, P; Charlier, N; Lemey, P; Billoir, F; Vandamme, AM; De Clercq, E; de Lamballerie, X; Neyts, J;
PUBLISHED: 2002, SOURCE: VIROLOGY, VOLUME: 293, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
275
TITLE: Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease resulting from a common source of infection  Full Text
AUTHORS: Duffy, M; Salemi, M; Sheehy, N; Vandamme, AM; Hegarty, J; Curry, M; Nolan, N; Kelleher, D; McKiernan, S; Hall, WW;
PUBLISHED: 2002, SOURCE: VIROLOGY, VOLUME: 301, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
276
TITLE: Reanalysis of the HIV-1 circulating recombinant form A/E (CRF01_AE): Evidence of A/E/G recombination
AUTHORS: Magiorkinis, G; Paraskevis, D; Magiorkinis, E; Vandamme, AM; Hatzakis, A;
PUBLISHED: 2002, SOURCE: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 30, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
277
TITLE: A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients
AUTHORS: Van Laethem, K; De Luca, A; Antinori, A; Cingolani, A; Perno, CF; Vandamme, AM;
PUBLISHED: 2002, SOURCE: ANTIVIRAL THERAPY, VOLUME: 7, ISSUE: 2
INDEXED IN: Scopus WOS
278
TITLE: A rapid phenotypic assay for detecting multiple nucleoside analogue reverse transcriptase inhibitor-resistant HIV-1 in plasma
AUTHORS: Qari, SH; Winters, M; Vandamme, AM; Merigan, T; Heneine, W;
PUBLISHED: 2002, SOURCE: ANTIVIRAL THERAPY, VOLUME: 7, ISSUE: 2
INDEXED IN: Scopus WOS
279
TITLE: A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure
AUTHORS: Van Vaerenbergh, K; De Geest, S; Derdelinckx, I; Bobbaers, H; Carbonez, A; Deschamps, A; De Graeve, V; De Saar, V; Ceunen, H; De Smet, K; Maes, B; Peetermans, W; Schrooten, Y; Desmyter, J; De Clercq, E; Van Ranst, M; Van Wijngaerden, E; Vandamme, AM;
PUBLISHED: 2002, SOURCE: Antiviral Chemistry and Chemotherapy, VOLUME: 13, ISSUE: 4
INDEXED IN: Scopus
IN MY: ORCID
280
TITLE: env chimeric virus technology for evaluating human immunodeficiency virus susceptibility to entry inhibitors
AUTHORS: Fikkert, V; Cherepanov, P; van Laethem, K; Hantson, A; Van Remoortel, B; Pannecouque, C; De Clercq, E; Debyser, Z; Vandamme, AM; Witvrouw, M;
PUBLISHED: 2002, SOURCE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 46, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef
Page 28 of 45. Total results: 443.